(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago. Jury selection began on Tuesday ...

Credit: Getty Images. A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists. Ranitidine does not pose an increased ...

Feb 16 (Reuters) - Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc's (GSK.L), opens new tab heartburn drug Zantac urged a California judge on Thursday to allow expert ...

[vc_text_separator title=”Partner Content”][rs_space lg_device=”5″ md_device=”” sm_device=”” xs_device=””] Zantac is a medication used to relieve various stomach problems. However, Zantac can also ...

(Reuters) -The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months. The case, brought by ...

(Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

Concerns that trace amounts of nitrosamine compounds in the H2 inhibitor drug ranitidine (Zantac) could cause cancer are unfounded, examination of health records for millions of people suggested.

A Delaware Superior Court judge will hear litigation Monday from plaintiffs who say their cancer was caused by the popular heartburn medication Zantac. The judge will be tasked with determining ...

A researcher prepares to test a bottle of Zantac 150 at the Valisure LLC lab in New Haven, Connecticut, US on Wednesday, Sept. 7, 2022. A meta-analysis suggests that ranitidine does not pose an ...

June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs ...